Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 10,000 SPRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 10,000 | n/a |
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 22, 2026 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 35,700 | n/a |
| Jun 16, 2026 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 31,000 | n/a |
| Jun 11, 2026 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 6,000 | n/a |
| Aug 13, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,302 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 17, 2025 | Spero Therapeutics, Inc. (SPRO) | Grant/Award | 20,000 | n/a |
| Jun 13, 2025 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 24,000 | n/a |
| Jun 11, 2025 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 35,700 | n/a |